The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 3 rounds in the feed, most often in Healthtech.
Venture capitalmissionbaycapital.comRounds from 2014-09-22 to 2019-08-07
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Glycomine Glycomine develops replacement therapies for rare genetic diseases, particularly focusing on PMM2-CDG treatments. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $33M | 2019-08-07 | [ PART ] |
Series A Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. |
| $4.5M |
| 2016-12-21 |
| [ LEAD ] |
Circle Pharma A biopharmaceutical company advancing CID-165 for ER-positive breast cancer | Seed Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | n/a | 2014-09-22 | [ PART ] |